Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients

Background: Acute minor ischemic stroke (AMIS) has been proven to be strongly associated with post-stroke cognitive impairment (PSCI). Few studies have reported that uric acid (UA) levels are linked to PSCI in patients with AMIS, and those results are debatable. We investigated the relationship betw...

Full description

Bibliographic Details
Main Authors: Lei Xu, Qing-rong Ouyang, Qin Xiong, Lu-wen Huang, Ming Yu
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023082804
_version_ 1827780239027077120
author Lei Xu
Qing-rong Ouyang
Qin Xiong
Lu-wen Huang
Ming Yu
author_facet Lei Xu
Qing-rong Ouyang
Qin Xiong
Lu-wen Huang
Ming Yu
author_sort Lei Xu
collection DOAJ
description Background: Acute minor ischemic stroke (AMIS) has been proven to be strongly associated with post-stroke cognitive impairment (PSCI). Few studies have reported that uric acid (UA) levels are linked to PSCI in patients with AMIS, and those results are debatable. We investigated the relationship between serum UA levels and cognitive impairment in patients with AMIS. Methods: A total of 318 patients who were diagnosed with AMIS were recruited from Suining Central Hospital. Fasting serum samples were collected the day after admission for UA measurement. Cognitive function was evaluated at admission and 3 months after stroke using the Montreal Cognitive Assessment (MoCA). The relationship between UA and PSCI was examined using a multivariate binary logistic regression model. The optimal cut-off point for UA levels to predict PSCI was determined using the receiver operating characteristic (ROC) curve. Results: A total of 197 (61.9 %) of the 318 participants in this study exhibited cognitive impairment at 3 months. Serum UA was strongly linked with PSCI after adjusting for confounding factors (OR = 1.82, 95 % CI: 1.56 to 2.11, P < 0.0001). The ROC curve revealed a cut-off of 363.58 μmol/L serum UA, and the predicted sensitivity and specificity for PSCI were 67.5 % and 83.5 %, respectively. Subgroup analysis showed that confounding factors had no impact on the association between serum UA and PSCI risk. Conclusions: Higher baseline serum UA levels might be an independent risk factor for cognitive impairment in AMIS patients. Serum UA levels above 363.58 μmol/L may have clinical implications in predicting PSCI.
first_indexed 2024-03-11T15:01:52Z
format Article
id doaj.art-80344097555a4df1879387a8c3fd8f5f
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-11T15:01:52Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-80344097555a4df1879387a8c3fd8f5f2023-10-30T06:08:17ZengElsevierHeliyon2405-84402023-10-01910e21072Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patientsLei Xu0Qing-rong Ouyang1Qin Xiong2Lu-wen Huang3Ming Yu4Department of Neurology, Suining Central Hospital, Suining, 629000, ChinaDepartment of Neurology, Suining Central Hospital, Suining, 629000, ChinaDepartment of Internal Medicine, The Third People's Hospital of Suining, Suining, 629099, ChinaDepartment of Neurology, Suining Central Hospital, Suining, 629000, ChinaDepartment of Neurology, Suining Central Hospital, Suining, 629000, China; Corresponding author.Background: Acute minor ischemic stroke (AMIS) has been proven to be strongly associated with post-stroke cognitive impairment (PSCI). Few studies have reported that uric acid (UA) levels are linked to PSCI in patients with AMIS, and those results are debatable. We investigated the relationship between serum UA levels and cognitive impairment in patients with AMIS. Methods: A total of 318 patients who were diagnosed with AMIS were recruited from Suining Central Hospital. Fasting serum samples were collected the day after admission for UA measurement. Cognitive function was evaluated at admission and 3 months after stroke using the Montreal Cognitive Assessment (MoCA). The relationship between UA and PSCI was examined using a multivariate binary logistic regression model. The optimal cut-off point for UA levels to predict PSCI was determined using the receiver operating characteristic (ROC) curve. Results: A total of 197 (61.9 %) of the 318 participants in this study exhibited cognitive impairment at 3 months. Serum UA was strongly linked with PSCI after adjusting for confounding factors (OR = 1.82, 95 % CI: 1.56 to 2.11, P < 0.0001). The ROC curve revealed a cut-off of 363.58 μmol/L serum UA, and the predicted sensitivity and specificity for PSCI were 67.5 % and 83.5 %, respectively. Subgroup analysis showed that confounding factors had no impact on the association between serum UA and PSCI risk. Conclusions: Higher baseline serum UA levels might be an independent risk factor for cognitive impairment in AMIS patients. Serum UA levels above 363.58 μmol/L may have clinical implications in predicting PSCI.http://www.sciencedirect.com/science/article/pii/S2405844023082804Uric acidCognitive impairmentIschemic strokeMontreal cognitive assessment
spellingShingle Lei Xu
Qing-rong Ouyang
Qin Xiong
Lu-wen Huang
Ming Yu
Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
Heliyon
Uric acid
Cognitive impairment
Ischemic stroke
Montreal cognitive assessment
title Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
title_full Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
title_fullStr Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
title_full_unstemmed Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
title_short Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
title_sort elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
topic Uric acid
Cognitive impairment
Ischemic stroke
Montreal cognitive assessment
url http://www.sciencedirect.com/science/article/pii/S2405844023082804
work_keys_str_mv AT leixu elevatedserumuricacidisassociatedwithcognitiveimpairmentinacuteminorischemicstrokepatients
AT qingrongouyang elevatedserumuricacidisassociatedwithcognitiveimpairmentinacuteminorischemicstrokepatients
AT qinxiong elevatedserumuricacidisassociatedwithcognitiveimpairmentinacuteminorischemicstrokepatients
AT luwenhuang elevatedserumuricacidisassociatedwithcognitiveimpairmentinacuteminorischemicstrokepatients
AT mingyu elevatedserumuricacidisassociatedwithcognitiveimpairmentinacuteminorischemicstrokepatients